{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:03:13Z","timestamp":1762077793904,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ahj.2023.11.012","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T04:56:08Z","timestamp":1700715368000},"page":"45-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effects of intensive blood pressure control on left ventricular hypertrophy in aortic valve disease"],"prefix":"10.1016","volume":"268","author":[{"given":"Mijin","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Hyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung-Kwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hack-Lyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hee","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Yoon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kye-Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geu-Ru","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Mi","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk-Hyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.11.012_bib0001","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.11.012_bib0002","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/08037050701343241","article-title":"Severe aortic stenosis and its association with hypertension: analysis of clinical and echocardiographic parameters","volume":"16","author":"Linhartov\u00e1","year":"2007","journal-title":"Blood Press"},{"key":"10.1016\/j.ahj.2023.11.012_bib0003","first-page":"e72","article-title":"2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.11.012_bib0004","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2004.10.081","article-title":"Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment","volume":"46","author":"Briand","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.11.012_bib0005","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jacc.2009.04.079","article-title":"Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis","volume":"54","author":"Hachicha","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.11.012_bib0006","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/HJH.0000000000000477","article-title":"Cardiovascular risk in relation to a new classification of hypertensive left ventricular geometric abnormalities","volume":"33","author":"de Simone","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2023.11.012_bib0007","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.11.012_bib0008","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1161\/CIRCULATIONAHA.113.005275","article-title":"Time to treat hypertension in patients with aortic stenosis","volume":"128","author":"Lindman","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.11.012_bib0009","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2023.11.012_bib0010","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/HJH.0000000000002426","article-title":"Hypertension in aortic stenosis: a focused review and recommendations for clinical practice","volume":"38","author":"Saeed","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2023.11.012_bib0011","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.11.012_bib0012","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.115.021213","article-title":"Assessing optimal blood pressure in patients with asymptomatic aortic valve stenosis: the simvastatin ezetimibe in aortic stenosis study (SEAS)","volume":"134","author":"Nielsen","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.11.012_bib0013","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCULATIONAHA.116.023688","article-title":"Management of hypertension in patients with mild to moderate aortic stenosis: navigating the SEAS","volume":"134","author":"O'Gara","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.11.012_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ahj.2023.11.012_bib0015","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.echo.2017.02.009","article-title":"Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"30","author":"Baumgartner","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ahj.2023.11.012_bib0016","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ahj.2023.11.012_bib0017","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0895-7061(04)00815-5","article-title":"Regression of left ventricular mass in hypertensive patients treated with perindopril\/indapamide as a first-line combination: the REASON echocardiography study","volume":"17","author":"de Luca","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ahj.2023.11.012_bib0018","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/hc3901.096700","article-title":"Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril","volume":"104","author":"Mathew","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.11.012_bib0019","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0895-7061(03)01018-5","article-title":"Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis","volume":"16","author":"Verdecchia","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ahj.2023.11.012_bib0020","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1001\/jama.292.19.2350","article-title":"Prognostic significance of left ventricular mass change during treatment of hypertension","volume":"292","author":"Devereux","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.ahj.2023.11.012_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014020","article-title":"Lower blood pressure after transcatheter or surgical aortic valve replacement is associated with increased mortality","volume":"8","author":"Lindman","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2023.11.012_bib0022","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/ehjcvp\/pvaa040","volume":"7","author":"Mancusi","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.ahj.2023.11.012_bib0023","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/eurheartj\/ehac395","article-title":"Hypertension management in patients with cardiovascular comorbidities","volume":"44","author":"Lauder","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.11.012_bib0024","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7326\/0003-4819-148-1-200801010-00189","article-title":"Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension","volume":"148","author":"Matchar","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2023.11.012_bib0025","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jacc.2011.01.063","article-title":"Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis","volume":"58","author":"Nadir","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.11.012_bib0026","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijcard.2014.06.013","article-title":"Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis","volume":"175","author":"Bang","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2023.11.012_bib0027","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jash.2015.11.005","article-title":"Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension","volume":"10","author":"Akioyamen","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.ahj.2023.11.012_bib0028","doi-asserted-by":"crossref","first-page":"e15287","DOI":"10.1371\/journal.pone.0015287","article-title":"High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy","volume":"6","author":"Tyralla","year":"2011","journal-title":"PLoS One"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323003216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323003216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:59:07Z","timestamp":1762077547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323003216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":28,"alternative-id":["S0002870323003216"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.11.012","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of intensive blood pressure control on left ventricular hypertrophy in aortic valve disease","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}